relate < related < relating

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 82.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000010 (2011)	Katsuaki Kanbe [Japon] ; Atsushi Nakamura [Japon] ; Yasuo Inoue [Japon] ; Kaori Hobo [Japon]	Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis
000020 (2011)	Taras Gout [Royaume-Uni] ; Andrew J. K. Östör [Royaume-Uni] ; Muhammad K. Nisar [Royaume-Uni]	Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review
000023 (2009)	Misato Hashizume [Japon] ; Yasushi Uchiyama [Japon] ; Naoto Horai [Japon] ; Naohisa Tomosugi [Japon] ; Masahiko Mihara [Japon]	Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production
000029 (2011)	Satoru Shinriki [Japon] ; Hirofumi Jono [Japon] ; Mitsuharu Ueda [Japon] ; Kazutoshi Ota [Japon] ; Tomoko Ota [Japon] ; Takanao Sueyoshi [Japon] ; Yuichi Oike [Japon] ; Mutsuko Ibusuki [Japon] ; Akimitsu Hiraki [Japon] ; Hideki Nakayama [Japon] ; Masanori Shinohara [Japon] ; Yukio Ando [Japon]	Interleukin‐6 signalling regulates vascular endothelial growth factor‐C synthesis and lymphangiogenesis in human oral squamous cell carcinoma
000058 (2014)	Lucie M. Turcotte [États-Unis] ; Colleen K. Correll ; Robyn C. Reed ; Christopher L. Moertel	Sustained remission of severe multicentric castleman disease following multiagent chemotherapy and tocilizumab maintenance
000066 (2013)	Kanae Tani [Japon] ; Risa Takayanagi [Japon] ; Haruko Yokoyama [Japon] ; Yasuhiko Yamada [Japon]	Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancy
000083 (2012)	Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon]	The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab
000089 (2013)	Alfredo Adán [Espagne] ; Marina Mesquida [Espagne] ; Victor Llorenç [Espagne] ; Gerard Espinosa [Espagne] ; Blanca Molins [Espagne] ; Maria V. Hernández [Espagne] ; Laura Pelegrín [Espagne]	Tocilizumab treatment for refractory uveitis-related cystoid macular edema
000125 (2012)	Nicolas Rohleder [États-Unis] ; Martin Aringer [Allemagne] ; Matthias Boentert [Allemagne]	Role of interleukin‐6 in stress, sleep, and fatigue
000144 (2012)	U. Lange [Allemagne] ; U. Müller-Ladner [Allemagne]	Potenzielle rheumatologische Medikamentenwechselwirkungen im Alter
000146 (2010)	G. Horneff [Allemagne]	Juvenile Arthritiden
000169 (2015)	Yanli Zhuang [États-Unis] ; Dick E. De Vries [Pays-Bas] ; Zhenhua Xu [États-Unis] ; Stanley J. Marciniak Jr. [États-Unis] ; Dion Chen [États-Unis] ; Francisco Leon [États-Unis] ; Hugh M. Davis [États-Unis] ; Honghui Zhou [États-Unis]	Evaluation of disease‐mediated therapeutic protein–drug interactions between an anti–interleukin‐6 monoclonal antibody (sirukumab) and cytochrome P450 activities in a phase 1 study in patients with rheumatoid arthritis using a cocktail approach
000181 (2015)	Yi Zhang [États-Unis] ; Xiaohui Wei [États-Unis] ; Gaurav Bajaj [États-Unis] ; Jeffrey S. Barrett [États-Unis] ; Bernd Meibohm [États-Unis] ; Amita Joshi [États-Unis] ; Manish Gupta [États-Unis]	Challenges and considerations for development of therapeutic proteins in pediatric patients
000199 (2015)	Yusuke Tsuma [Japon] ; Toshihiko Imamura [Japon] ; Eisuke Ichise [Japon] ; Kenichi Sakamoto [Japon] ; Kazutaka Ouchi [Japon] ; Shinya Osone [Japon] ; Hiroyuki Ishida [Japon] ; Taizo Wada [Japon] ; Hajime Hosoi [Japon]	Successful treatment of idiopathic colitis related to XIAP deficiency with allo‐HSCT using reduced‐intensity conditioning
000205 (2012)	A. Rubbert-Roth [Allemagne] ; H.-F. Petereit [Allemagne]	Nebenwirkungen der medikamentösen Therapie rheumatischer Erkrankungen am Nervensystem
000211 (2006)	Lyndell Lim [États-Unis] ; Eric B. Suhler [États-Unis] ; Justine R. Smith [États-Unis]	Biologic therapies for inflammatory eye disease
000233 (2010)	Hiroshi Kato [États-Unis] ; David A. Fox [États-Unis]	Are Th17 Cells an Appropriate New Target in the Treatment of Rheumatoid Arthritis?
000246 (2011)	Bernard Bannwarth [France]	Prise en charge thérapeutique de l’inflammation d’origine rhumatismale
000273 (2012)	T. Adizie ; D. Christidis ; C. Dharmapaliah ; F. Borg ; B. Dasgupta [Royaume-Uni]	Efficacy and tolerability of leflunomide in difficult‐to‐treat polymyalgia rheumatica and giant cell arteritis: a case series
000292 (2010)	W. Graninger [Autriche]	Die immunmodulierende Therapie verbessert die Lebensqualität bei rheumatoider Arthritis
000303 (2013)	Verena Wieser [Autriche] ; Alexander R. Moschen [Autriche] ; Herbert Tilg [Autriche]	Inflammation, Cytokines and Insulin Resistance: A Clinical Perspective

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "related" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "related" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    related
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021